Naturally occurring, produced by fungi such as Aspergillus and Penicillium during fermentation — a byproduct of Japanese processes like sake, soy sauce and rice-wine brewing.

Its established benefit is brightening and evening of tone. It inhibits tyrosinase, the rate-limiting, copper-containing enzyme skin uses to make melanin — the pigment behind dark spots, sun damage and melasma. Kojic acid chelates the copper at tyrosinase's active site, exerting competitive and mixed inhibition, so new pigment forms more slowly and existing discolouration can gradually fade. It also contributes antioxidant, free-radical-scavenging activity.

It is the most evidence-backed ingredient here, tested in multiple randomised human trials both alone and as an adjunct to hydroquinone and glycolic acid.

• Deo KS, et al. (2013) Kojic acid vis-a-vis its combinations with hydroquinone and betamethasone valerate in melasma (randomised, single-blind trial). Indian Journal of Dermatology, 58(4):281–285. 80 patients, 12 weeks. Kojic acid 1% alone cut MASI scores 59%; 72% combined with hydroquinone.
• Lim JT (1999) Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid. Dermatologic Surgery, 25(4):282–284. Split-face study of 40 women; adding 2% kojic acid improved melasma further.
• Saeedi M, et al. (2019) Kojic acid applications in cosmetic and pharmaceutical preparations. Biomedicine & Pharmacotherapy, 110:582–593.
• Zilles JC, et al. (2022) Biological activities and safety data of kojic acid and its derivatives: a review. Experimental Dermatology, 31(10):1500–1521.

Turmeric (Curcuma longa) and its principal polyphenol curcumin have a long history in traditional medicine and a growing body of research supporting antioxidant, anti-inflammatory and skin-soothing benefits. Curcumin neutralises reactive oxygen species and downregulates inflammatory signalling — notably NF-κB — which helps calm the look of redness and protect against oxidative stress.

Lab studies show curcumin can inhibit tyrosinase, giving it a plausible supporting role in brightening alongside kojic acid.

The honest caveat is bioavailability. Curcumin is poorly water-soluble and penetrates skin with difficulty, so real-world potency depends heavily on formulation. It is best described as a natural antioxidant and soothing agent rather than a proven stand-alone dark-spot treatment — which is how we describe it.

• Vaughn AR, et al. (2016) Effects of turmeric on skin health: a systematic review of the clinical evidence. Phytotherapy Research, 30(8):1243–1264. Of 18 qualifying studies, 10 showed significant improvement; the authors note the evidence remains early and limited.
• Di Lorenzo R, et al. (2023) Clinical studies on topical curcumin. Skin Pharmacology and Physiology, 36(5):235–248.
• Zhang Y, et al. (2024) Curcumin-mediated photodynamic therapy for mild-to-moderate acne (split-face trial). Photodiagnosis and Photodynamic Therapy, 45:103887. 54.7% lesion clearance vs. 28.1% for light alone — but only 11 patients, and the curcumin was light-activated, which a pad is not.

A form of vitamin B3, and one of the most extensively studied multi-tasking actives in skincare.

For tone it complements kojic acid rather than duplicating it: instead of blocking pigment production, niacinamide inhibits the transfer of pigment-filled melanosomes from melanocytes to the surface skin cells, which visibly reduces the appearance of dark spots and uneven tone.

It also strengthens the barrier by stimulating ceramide synthesis and reducing transepidermal water loss, and has documented anti-inflammatory and sebum-regulating effects that benefit oily and blemish-prone skin.

• Hakozaki T, et al. (2002) The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. British Journal of Dermatology, 147(1):20–31. 35–68% inhibition of melanosome transfer in a lab coculture model; separately, significant clinical lightening at 5% in an 18-subject trial.
• Navarrete-Solís J, et al. (2011) A double-blind, randomised clinical trial of niacinamide 4% versus hydroquinone 4% in melasma. Dermatology Research and Practice, 2011:379173. Comparable results, with fewer side effects.
• Bissett DL, et al. (2004) Topical niacinamide reduces yellowing, wrinkling, red blotchiness and hyperpigmented spots in aging facial skin. International Journal of Cosmetic Science, 26(5):231–238.

A water-soluble antioxidant that supports a brighter, more even-looking tone through several mechanisms at once: it scavenges free radicals generated by UV and pollution, interrupts melanin formation by acting on tyrosinase and reducing already-darkened melanin back to a lighter state, and is an essential cofactor for the enzymes that build collagen.

The caveat is stability and penetration. Pure L-ascorbic acid oxidises easily and does not cross the skin barrier efficiently, which is why brightening pads often pair it with low-pH acids or use more stable derivatives.

• Huh CH, et al. (2003) A randomized, double-blind, placebo-controlled trial of vitamin C iontophoresis in melasma. Dermatology, 206(4):316–320.
• Correia G, Magina S (2023) Efficacy of topical vitamin C in melasma and photoaging: a systematic review. Journal of Cosmetic Dermatology, 22(7):1938–1945.

Glycolic acid is the smallest of the alpha hydroxy acids — small enough to penetrate readily — and the best studied. It works by loosening the bonds between dead cells at the skin's surface, so they lift away instead of accumulating and dulling the complexion. With continued use it also supports remodelling in the deeper dermis.

For this product the relevant part is turnover: by speeding the rate at which surface cells are shed, glycolic acid helps pigment already sitting in those cells clear sooner, which improves the appearance of post-inflammatory marks and uneven tone. It complements kojic acid rather than repeating it — kojic acid slows new pigment being made, glycolic acid helps existing pigment leave.

It also lowers the formula's pH, which is the environment the brightening actives need to stay effective.

• Sharad J (2013) Glycolic acid peel therapy: a current review. Clinical, Cosmetic and Investigational Dermatology, 6:281–288.
• Stiller MJ, et al. (1996) Topical 8% glycolic acid and 8% L-lactic acid creams for photodamaged skin (double-blind, vehicle-controlled). Archives of Dermatology, 132(6):631–636.

Ginger rhizome is rich in gingerols, and — as it dries or is heated — the shogaols they convert into. These are the pungent polyphenols behind both its taste and its documented antioxidant and anti-inflammatory activity.

In laboratory work these compounds scavenge free radicals and quiet the inflammatory signalling that UV sets off in skin cells. [6]-Shogaol has also been shown to suppress melanin production by speeding the breakdown of MITF — the master switch that turns on tyrosinase, the same enzyme kojic acid inhibits. That is a specific, genuine mechanism, and it is a coherent reason to put ginger in a brightening formula.

The honest caveat is that this is lab evidence, not skin evidence. Every study below is cultured cells or mice. We could find no topical human trial of ginger extract for dark spots or uneven tone — so ginger sits here as a supporting antioxidant with promising laboratory data behind it, and we do not stretch it further than that.

• Guahk GH, et al. (2010) Zingiber officinale protects HaCaT cells and C57BL/6 mice from ultraviolet B-induced inflammation. Journal of Medicinal Food, 13(3):673–680. Ginger extract, gingerol and shogaol each cut inflammatory cytokines in UVB-exposed human keratinocytes; ginger also reduced UVB-induced hyperplasia in mice. Cells and animals — not people.
• Huang HC, et al. (2014) [6]-Shogaol inhibits α-MSH-induced melanogenesis through the acceleration of ERK and PI3K/Akt-mediated MITF degradation. BioMed Research International, 2014:842569. Suppressed tyrosinase activity and melanin content more than arbutin did — in cultured cells, which is a long way from a pad on a face.
• Yao C, et al. (2013) [6]-Shogaol inhibits melanogenesis in B16 mouse melanoma cells through activation of the ERK pathway. Acta Pharmacologica Sinica, 34(2):289–294. Mouse melanoma cells in a dish.

Papaya (Carica papaya) fruit and latex contain papain, a cysteine protease — an enzyme that cuts protein chains apart. On skin the proteins that matter are the corneodesmosomes: the protein rivets holding dead cells onto the surface. Skin sheds those cells using its own papain-like enzymes, and applied papain is a keratolytic working by that same chemistry — loosening the rivets so dull surface cells lift away sooner. Papaya also brings carotenoids and vitamin C along with it.

This is an exfoliating mechanism, not a pigment-blocking one. Unlike kojic acid, papaya does not act on tyrosinase — we looked, and found no published evidence that it does. Its contribution to an even-looking tone is the ordinary contribution of any exfoliant: pigment sitting in surface cells clears sooner when those cells turn over faster.

Two honest caveats. The topical human evidence for papaya on tone is missing rather than negative — what exists below is a mechanism review and a mouse burn model. And papain is a well-documented allergen, capable of sensitising skin through its protease activity itself, which makes the patch test on the fine print a real instruction rather than a formality.

• Brocklehurst K, Philpott MP (2013) Cysteine proteases: mode of action and role in epidermal differentiation. Cell and Tissue Research, 351(2):237–244. How papain-like cysteine proteases break down the corneodesmosomes that hold dead surface cells together. This describes the skin's own shedding enzymes — it is the mechanism applied papain borrows, not a study of papaya.
• Gurung S, Skalko-Basnet N (2009) Wound healing properties of Carica papaya latex: in vivo evaluation in mice burn model. Journal of Ethnopharmacology, 121(2):338–341. Papaya latex gel shortened healing time in burned mice. An animal wound model — it says nothing about tone in humans, and we cite it only because it is the real evidence that exists.
• Giangrieco I, et al. (2024) Plant and arthropod IgE-binding papain-like cysteine proteases: multiple contributions to allergenicity. Foods, 13(5):790. Papain is a recognised allergen, and its protease activity contributes to that directly. Cited here because it counts against the ingredient, not for it.

Carrot (Daucus carota) supplies beta-carotene — provitamin A, the dietary precursor the body converts into vitamin A — alongside alpha-carotene, lutein and other carotenoids. Carotenoids are efficient quenchers of singlet oxygen, one of the reactive species UV generates in skin. That antioxidant chemistry is not in dispute.

Two things it is worth being straight about. Beta-carotene is a precursor to vitamin A, not a retinoid, and it should not be expected to behave like one on skin — this is not a retinol product. And the question that actually matters for a pad is whether applying carotenoids does what eating them does.

The honest caveat is the route. The human evidence for beta-carotene and skin is dietary. The pooled supplementation studies below found modest protection against sunburn — and only after ten weeks or more of taking it by mouth. A carrot extract in a pad is not that, and we will not present it as though it were. Topical human data for carrot extract on dark spots is, as far as we can find, simply absent. It is here as an antioxidant, not as a brightener.

• Köpcke W, Krutmann J (2008) Protection from sunburn with beta-carotene — a meta-analysis. Photochemistry and Photobiology, 84(2):284–288. Pooled seven human supplementation studies. Protection appeared only after at least 10 weeks, growing with duration — and throughout, the beta-carotene was swallowed, not applied.
• Stahl W, Sies H (2012) β-Carotene and other carotenoids in protection from sunlight. American Journal of Clinical Nutrition, 96(5):1179S–1184S.

Naturally occurring, produced by fungi such as Aspergillus and Penicillium during fermentation — a byproduct of Japanese processes like sake, soy sauce and rice-wine brewing.

Its established benefit is brightening and evening of tone. It inhibits tyrosinase, the rate-limiting, copper-containing enzyme skin uses to make melanin — the pigment behind dark spots, sun damage and melasma. Kojic acid chelates the copper at tyrosinase's active site, exerting competitive and mixed inhibition, so new pigment forms more slowly and existing discolouration can gradually fade. It also contributes antioxidant, free-radical-scavenging activity.

It is the most evidence-backed ingredient here, tested in multiple randomised human trials both alone and as an adjunct to hydroquinone and glycolic acid.

• Deo KS, et al. (2013) Kojic acid vis-a-vis its combinations with hydroquinone and betamethasone valerate in melasma (randomised, single-blind trial). Indian Journal of Dermatology, 58(4):281–285. 80 patients, 12 weeks. Kojic acid 1% alone cut MASI scores 59%; 72% combined with hydroquinone.
• Lim JT (1999) Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid. Dermatologic Surgery, 25(4):282–284. Split-face study of 40 women; adding 2% kojic acid improved melasma further.
• Saeedi M, et al. (2019) Kojic acid applications in cosmetic and pharmaceutical preparations. Biomedicine & Pharmacotherapy, 110:582–593.
• Zilles JC, et al. (2022) Biological activities and safety data of kojic acid and its derivatives: a review. Experimental Dermatology, 31(10):1500–1521.

Turmeric (Curcuma longa) and its principal polyphenol curcumin have a long history in traditional medicine and a growing body of research supporting antioxidant, anti-inflammatory and skin-soothing benefits. Curcumin neutralises reactive oxygen species and downregulates inflammatory signalling — notably NF-κB — which helps calm the look of redness and protect against oxidative stress.

Lab studies show curcumin can inhibit tyrosinase, giving it a plausible supporting role in brightening alongside kojic acid.

The honest caveat is bioavailability. Curcumin is poorly water-soluble and penetrates skin with difficulty, so real-world potency depends heavily on formulation. It is best described as a natural antioxidant and soothing agent rather than a proven stand-alone dark-spot treatment — which is how we describe it.

• Vaughn AR, et al. (2016) Effects of turmeric on skin health: a systematic review of the clinical evidence. Phytotherapy Research, 30(8):1243–1264. Of 18 qualifying studies, 10 showed significant improvement; the authors note the evidence remains early and limited.
• Di Lorenzo R, et al. (2023) Clinical studies on topical curcumin. Skin Pharmacology and Physiology, 36(5):235–248.
• Zhang Y, et al. (2024) Curcumin-mediated photodynamic therapy for mild-to-moderate acne (split-face trial). Photodiagnosis and Photodynamic Therapy, 45:103887. 54.7% lesion clearance vs. 28.1% for light alone — but only 11 patients, and the curcumin was light-activated, which a pad is not.

A form of vitamin B3, and one of the most extensively studied multi-tasking actives in skincare.

For tone it complements kojic acid rather than duplicating it: instead of blocking pigment production, niacinamide inhibits the transfer of pigment-filled melanosomes from melanocytes to the surface skin cells, which visibly reduces the appearance of dark spots and uneven tone.

It also strengthens the barrier by stimulating ceramide synthesis and reducing transepidermal water loss, and has documented anti-inflammatory and sebum-regulating effects that benefit oily and blemish-prone skin.

• Hakozaki T, et al. (2002) The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. British Journal of Dermatology, 147(1):20–31. 35–68% inhibition of melanosome transfer in a lab coculture model; separately, significant clinical lightening at 5% in an 18-subject trial.
• Navarrete-Solís J, et al. (2011) A double-blind, randomised clinical trial of niacinamide 4% versus hydroquinone 4% in melasma. Dermatology Research and Practice, 2011:379173. Comparable results, with fewer side effects.
• Bissett DL, et al. (2004) Topical niacinamide reduces yellowing, wrinkling, red blotchiness and hyperpigmented spots in aging facial skin. International Journal of Cosmetic Science, 26(5):231–238.

A water-soluble antioxidant that supports a brighter, more even-looking tone through several mechanisms at once: it scavenges free radicals generated by UV and pollution, interrupts melanin formation by acting on tyrosinase and reducing already-darkened melanin back to a lighter state, and is an essential cofactor for the enzymes that build collagen.

The caveat is stability and penetration. Pure L-ascorbic acid oxidises easily and does not cross the skin barrier efficiently, which is why brightening pads often pair it with low-pH acids or use more stable derivatives.

• Huh CH, et al. (2003) A randomized, double-blind, placebo-controlled trial of vitamin C iontophoresis in melasma. Dermatology, 206(4):316–320.
• Correia G, Magina S (2023) Efficacy of topical vitamin C in melasma and photoaging: a systematic review. Journal of Cosmetic Dermatology, 22(7):1938–1945.

Glycolic acid is the smallest of the alpha hydroxy acids — small enough to penetrate readily — and the best studied. It works by loosening the bonds between dead cells at the skin's surface, so they lift away instead of accumulating and dulling the complexion. With continued use it also supports remodelling in the deeper dermis.

For this product the relevant part is turnover: by speeding the rate at which surface cells are shed, glycolic acid helps pigment already sitting in those cells clear sooner, which improves the appearance of post-inflammatory marks and uneven tone. It complements kojic acid rather than repeating it — kojic acid slows new pigment being made, glycolic acid helps existing pigment leave.

It also lowers the formula's pH, which is the environment the brightening actives need to stay effective.

• Sharad J (2013) Glycolic acid peel therapy: a current review. Clinical, Cosmetic and Investigational Dermatology, 6:281–288.
• Stiller MJ, et al. (1996) Topical 8% glycolic acid and 8% L-lactic acid creams for photodamaged skin (double-blind, vehicle-controlled). Archives of Dermatology, 132(6):631–636.

Ginger rhizome is rich in gingerols, and — as it dries or is heated — the shogaols they convert into. These are the pungent polyphenols behind both its taste and its documented antioxidant and anti-inflammatory activity.

In laboratory work these compounds scavenge free radicals and quiet the inflammatory signalling that UV sets off in skin cells. [6]-Shogaol has also been shown to suppress melanin production by speeding the breakdown of MITF — the master switch that turns on tyrosinase, the same enzyme kojic acid inhibits. That is a specific, genuine mechanism, and it is a coherent reason to put ginger in a brightening formula.

The honest caveat is that this is lab evidence, not skin evidence. Every study below is cultured cells or mice. We could find no topical human trial of ginger extract for dark spots or uneven tone — so ginger sits here as a supporting antioxidant with promising laboratory data behind it, and we do not stretch it further than that.

• Guahk GH, et al. (2010) Zingiber officinale protects HaCaT cells and C57BL/6 mice from ultraviolet B-induced inflammation. Journal of Medicinal Food, 13(3):673–680. Ginger extract, gingerol and shogaol each cut inflammatory cytokines in UVB-exposed human keratinocytes; ginger also reduced UVB-induced hyperplasia in mice. Cells and animals — not people.
• Huang HC, et al. (2014) [6]-Shogaol inhibits α-MSH-induced melanogenesis through the acceleration of ERK and PI3K/Akt-mediated MITF degradation. BioMed Research International, 2014:842569. Suppressed tyrosinase activity and melanin content more than arbutin did — in cultured cells, which is a long way from a pad on a face.
• Yao C, et al. (2013) [6]-Shogaol inhibits melanogenesis in B16 mouse melanoma cells through activation of the ERK pathway. Acta Pharmacologica Sinica, 34(2):289–294. Mouse melanoma cells in a dish.

Papaya (Carica papaya) fruit and latex contain papain, a cysteine protease — an enzyme that cuts protein chains apart. On skin the proteins that matter are the corneodesmosomes: the protein rivets holding dead cells onto the surface. Skin sheds those cells using its own papain-like enzymes, and applied papain is a keratolytic working by that same chemistry — loosening the rivets so dull surface cells lift away sooner. Papaya also brings carotenoids and vitamin C along with it.

This is an exfoliating mechanism, not a pigment-blocking one. Unlike kojic acid, papaya does not act on tyrosinase — we looked, and found no published evidence that it does. Its contribution to an even-looking tone is the ordinary contribution of any exfoliant: pigment sitting in surface cells clears sooner when those cells turn over faster.

Two honest caveats. The topical human evidence for papaya on tone is missing rather than negative — what exists below is a mechanism review and a mouse burn model. And papain is a well-documented allergen, capable of sensitising skin through its protease activity itself, which makes the patch test on the fine print a real instruction rather than a formality.

• Brocklehurst K, Philpott MP (2013) Cysteine proteases: mode of action and role in epidermal differentiation. Cell and Tissue Research, 351(2):237–244. How papain-like cysteine proteases break down the corneodesmosomes that hold dead surface cells together. This describes the skin's own shedding enzymes — it is the mechanism applied papain borrows, not a study of papaya.
• Gurung S, Skalko-Basnet N (2009) Wound healing properties of Carica papaya latex: in vivo evaluation in mice burn model. Journal of Ethnopharmacology, 121(2):338–341. Papaya latex gel shortened healing time in burned mice. An animal wound model — it says nothing about tone in humans, and we cite it only because it is the real evidence that exists.
• Giangrieco I, et al. (2024) Plant and arthropod IgE-binding papain-like cysteine proteases: multiple contributions to allergenicity. Foods, 13(5):790. Papain is a recognised allergen, and its protease activity contributes to that directly. Cited here because it counts against the ingredient, not for it.

Carrot (Daucus carota) supplies beta-carotene — provitamin A, the dietary precursor the body converts into vitamin A — alongside alpha-carotene, lutein and other carotenoids. Carotenoids are efficient quenchers of singlet oxygen, one of the reactive species UV generates in skin. That antioxidant chemistry is not in dispute.

Two things it is worth being straight about. Beta-carotene is a precursor to vitamin A, not a retinoid, and it should not be expected to behave like one on skin — this is not a retinol product. And the question that actually matters for a pad is whether applying carotenoids does what eating them does.

The honest caveat is the route. The human evidence for beta-carotene and skin is dietary. The pooled supplementation studies below found modest protection against sunburn — and only after ten weeks or more of taking it by mouth. A carrot extract in a pad is not that, and we will not present it as though it were. Topical human data for carrot extract on dark spots is, as far as we can find, simply absent. It is here as an antioxidant, not as a brightener.

• Köpcke W, Krutmann J (2008) Protection from sunburn with beta-carotene — a meta-analysis. Photochemistry and Photobiology, 84(2):284–288. Pooled seven human supplementation studies. Protection appeared only after at least 10 weeks, growing with duration — and throughout, the beta-carotene was swallowed, not applied.
• Stahl W, Sies H (2012) β-Carotene and other carotenoids in protection from sunlight. American Journal of Clinical Nutrition, 96(5):1179S–1184S.